Evolution Research Group Acquires Richmond Behavioral Associates

Evolution Research Group (ERG), an independent clinical research site company with a focus in neuroscience and other special populations, has acquired Staten Island, New York-based Richmond Behavioral Associates (RBA). Founded by Mark DiBuono, M.D., and Adam Smith, Ph.D., RBA has been conducting CNS clinical trials for over 14 years across a broad range of illnesses including depression, anxiety disorders, schizophrenia, bipolar disorder, cognitive impairment, Alzheimer's disease, and autism, in both pediatric and adult populations.

According to Andria Chastain, chief operating officer of ERG, RBA’s history of delivering results in complex outpatient trials, mainly with children . . .